Shikari® (S-ATOCR) Anti-Ocrelizumab ELISA w/confirmation
OCR-QNS-OCR
Enzyme immunoassay for the quantitative determination of antibodies to of Ocrelizumab (Ocrevus®) in serum and plasma with confirmation.
This kit has been especially developed for the quantitative antibodies to Ocrelizumab in serum and plasma samples
This kit can be efficiently used for monitoring anti- ocrelizumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-ocrelizumab antibodies.
All SHIKARI® ELISA kits are suitable for biosimilar work.
All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.
For technical inquiry, please contact techsupport@matriksbiotek.com
| Required Volume (µl) | 20 |
| Total Time (min) | 140 |
| Sample | Serum, plasma |
| Sample Number | 96 |
| Detection Limit (ng/mL) | 7,5 |
| Spike Recovery (%) | Between 85-115 |
| Shelf Life (year) | 1 |
| Assay type | Quantitative |
| Species Reactivity | Human |
| Storage conditions | Store at +4°C. Please refer to protocols. |
| Shipping conditions | At room temperature |